Mel McLaughlin and her late sister were both nonsmokers ...

Social media advertising reached over one million adults eligible for lung cancer screening, showing a scalable way to boost ...

Host Jennifer Blomquist welcomes Dr. Alan Yahanda for an in-depth conversation about lung cancer. In this week’s episode of HealthLine on PBS Fort Wayne, host Jennifer Blomquist welcomes Dr. Alan ...

SAN ANTONIO — An enormous inflatable lung is drawing attention at the START Cancer Center — also known as South Texas Oncology and Hematology — in the Medical Center. The “Mega Lung,” an ...

How Lung cancer screenings could save your life. News 9 invites experts to talk about Lung cancer awareness live in-studio. Lung Cancer is the number one cause of death for Americans, even when ...

In 2022, lung cancer saw nearly 2.5 million new diagnoses (12.4% of all cancers) and caused an estimated 1.8 million deaths globally. Lung cancer is considered responsible for the most deaths due to ...

Only 19.2% of high-risk residents in NC get screened for lung cancer. Non-profit Lung Cancer Initiative is partnering with healthcare providers to raise awareness and combat high incidence. North ...

SEATTLE — November is Lung Cancer Awareness Month, and experts say early detection can make the difference between life and death. “Lung cancer affects about 50 of every 100,000 Washingtonians,” said ...

COLUMBIA, S.C. (WCSC) - South Carolinians are bringing awareness to the fight against one of the state’s most devastating cancers. On Tuesday, Gov. Henry McMaster proclaimed November as Lung Cancer ...

November is Lung Cancer Awareness Month, and medical professionals want people to know that early detection can save lives. Lung cancer is the leading cause of cancer deaths in the U.S. But according ...

SHREVEPORT, La. - Lung cancer remains the deadliest cancer in the U.S., but doctors say much of that risk is preventable. Occupational hazards like repeated exposure to ionizing radiation, diesel ...

Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations ...